Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home (EFIRAD)

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Bone and Joint Infection

Treatments

Other: pharmaceutical interview

Study type

Interventional

Funder types

Other

Identifiers

NCT05248490

APHP211422

2021-A02433-38 (Registry Identifier)

Details and patient eligibility

About

The primary objective is to evaluate the impact of Pharmaceutical Interviews in the patient self-management of non-severe side effects caused by antibiotics prescribed for the treatment of osteoarticular infections when the patient returns home.

Enrollment

90 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient > or =18 years;
Informed consent signed;
French-speaking and reading;
Affiliated to a social insurance;
Benefiting from medical and surgical care for an osteoarticular infection;
Treated with an oral antibiotic therapy on discharge from hospital.
Indication of the antibiotic therapy osteoarticular infection;
Return home immediately after discharge.

Exclusion criteria

Refusal to participate
Protected adult patient, under guardianship or curatorship.
Minor patient
Patient benefiting from an AME.
Pregnant or breastfeeding woman.
Non-French speaking patient.
Patient unable to understand the course of the study.
Patient with a documented history of cognitive or psychiatric disorders.
Patient treated with oral antibiotic therapy for an indication other than osteoarticular infection.
Patient treated with parenteral antibiotic therapy.
Discharge: Institution (EHPAD), rehabilitation or other health establishment.
Patient systematically using one of the symptomatic treatments proposed in the discharge prescription before hospitalization.